Lung cancer: diagnosis, treatment principles, and screening
- PMID: 25955626
Lung cancer: diagnosis, treatment principles, and screening
Abstract
Lung cancer is classified histologically into small cell and non-small cell lung cancers. The most common symptoms of lung cancer are cough, dyspnea, hemoptysis, and systemic symptoms such as weight loss and anorexia. High-risk patients who present with symptoms should undergo chest radiography. If a likely alternative diagnosis is not identified, computed tomography and possibly positron emission tomography should be performed. If suspicion for lung cancer is high, a diagnostic evaluation is warranted. The diagnostic evaluation has three simultaneous steps (tissue diagnosis, staging, and functional evaluation), all of which affect treatment planning and determination of prognosis. The least invasive method possible should be used. The diagnostic evaluation and treatment of a patient with lung cancer require a team of specialists, including a pulmonologist, medical oncologist, radiation oncologist, pathologist, radiologist, and thoracic surgeon. Non-small cell lung cancer specimens are tested for various mutations, which, if present, can be treated with new targeted molecular therapies. The family physician should remain involved in the patient's care to ensure that the values and wishes of the patient and family are considered and, if necessary, to coordinate end-of-life care. Early palliative care improves quality of life and may prolong survival. Family physicians should concentrate on early recognition of lung cancer, as well as prevention by encouraging tobacco cessation at every visit. The U.S. Preventive Services Task Force recommends lung cancer screening using low-dose computed tomography in high-risk patients. However, the American Academy of Family Physicians concludes that the evidence is insufficient to recommend for or against screening. Whether to screen high-risk patients should be a shared decision between the physician and patient.
Similar articles
-
Lung Cancer: Diagnosis, Treatment Principles, and Screening.Am Fam Physician. 2022 May 1;105(5):487-494. Am Fam Physician. 2022. PMID: 35559635
-
Lung cancer: diagnosis and management.Am Fam Physician. 2007 Jan 1;75(1):56-63. Am Fam Physician. 2007. PMID: 17225705 Review.
-
Lung Cancer: Clinical Presentation and Diagnosis.FP Essent. 2018 Jan;464:23-26. FP Essent. 2018. PMID: 29313654 Review.
-
How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? A short report.Eur J Cancer. 2012 Sep;48(14):2163-5. doi: 10.1016/j.ejca.2012.04.006. Epub 2012 May 26. Eur J Cancer. 2012. PMID: 22633748
-
Screening for cancer: concepts and controversies.Am Fam Physician. 2014 Nov 1;90(9):625-31. Am Fam Physician. 2014. PMID: 25368922
Cited by
-
Current Evidence for a Lung Cancer Screening Program.Port J Public Health. 2024 Apr 22;42(2):133-158. doi: 10.1159/000538434. eCollection 2024 Aug. Port J Public Health. 2024. PMID: 39469231 Free PMC article. Review.
-
Long Non-Coding RNA AGAP2-AS1: A Comprehensive Overview on Its Biological Functions and Clinical Significances in Human Cancers.Molecules. 2024 Jul 24;29(15):3461. doi: 10.3390/molecules29153461. Molecules. 2024. PMID: 39124865 Free PMC article. Review.
-
Functional Significance of Mirna-149 in Lung Cancer: Can it be Utilized as a Potential Biomarker or a Therapeutic Target?Austin J Med Oncol. 2020;7(1):1048. doi: 10.26420/austinjmedoncol.2020.1048. Epub 2020 Jun 17. Austin J Med Oncol. 2020. PMID: 38628497 Free PMC article.
-
Bilateral Adrenal Hemorrhage Heralds Bronchogenic Carcinoma.Cureus. 2024 Jan 11;16(1):e52109. doi: 10.7759/cureus.52109. eCollection 2024 Jan. Cureus. 2024. PMID: 38347972 Free PMC article.
-
Machine Learning Techniques to Predict Timeliness of Care among Lung Cancer Patients.Healthcare (Basel). 2023 Oct 18;11(20):2756. doi: 10.3390/healthcare11202756. Healthcare (Basel). 2023. PMID: 37893830 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
